PERSPECTIVE THERAPEUTICS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$3.33 million for the 12-month period ending 2018-06-30, per its 10-K filed 2018-09-26.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-09-26
- PERSPECTIVE THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $235.00K, a 71.75% decline year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$586.00K.
- PERSPECTIVE THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$1.00M.
- PERSPECTIVE THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$1.98M.
- PERSPECTIVE THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$3.33M.
- PERSPECTIVE THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$4.21M, a 185.65% decline from fiscal 2016.
- PERSPECTIVE THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $4.91M.
- PERSPECTIVE THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$2.45M, a 151.32% decline from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-26 | -$351.00K derived: sum of 2 quarters · filed 2018-09-26 | -$1.36M derived: sum of 3 quarters · filed 2018-09-26 | -$3.33M 10-K · filed 2018-09-26 | ||||
| 2018-03-31 | -$586.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-04 | -$1.59M derived: sum of 2 quarters · filed 2018-05-04 | -$3.57M 10-Q · filed 2018-05-04 | -$2.73M derived: sum of 4 quarters · filed 2018-09-26 | ||||
| 2017-12-31 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-09 | -$2.98M 10-Q · filed 2018-02-09 | -$2.15M derived: sum of 3 quarters · filed 2018-09-26 | -$3.72M derived: sum of 4 quarters · filed 2018-09-26 | ||||
| 2017-09-30 | -$1.98M 10-Q · filed 2017-11-14 | -$1.14M derived: sum of 2 quarters · filed 2018-09-26 | -$2.71M derived: sum of 3 quarters · filed 2018-09-26 | -$4.50M derived: sum of 4 quarters · filed 2018-09-26 | ||||
| 2017-06-30 | $832.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-26 | -$736.00K derived: sum of 2 quarters · filed 2018-09-26 | -$2.53M derived: sum of 3 quarters · filed 2018-09-26 | -$4.21M 10-K · filed 2018-09-26 | ||||
| 2017-03-31 | -$1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-04 | -$3.36M derived: sum of 2 quarters · filed 2018-05-04 | -$5.04M 10-Q · filed 2018-05-04 | -$594.00K derived: sum of 4 quarters · filed 2018-09-26 | ||||
| 2016-12-31 | -$1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-09 | -$3.47M 10-Q · filed 2018-02-09 | $974.00K derived: sum of 3 quarters · filed 2018-09-26 | $5.99M derived: sum of 4 quarters · filed 2018-09-26 | ||||
| 2016-09-30 | -$1.68M 10-Q · filed 2017-11-14 | $2.77M derived: sum of 2 quarters · filed 2018-09-26 | $7.78M derived: sum of 3 quarters · filed 2018-09-26 | $6.87M derived: sum of 4 quarters · filed 2018-09-26 | ||||
| 2016-06-30 | $4.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-26 | $9.46M derived: sum of 2 quarters · filed 2018-09-26 | $8.55M derived: sum of 3 quarters · filed 2018-09-26 | $4.91M 10-K · filed 2018-09-26 | $4.91M 10-K · filed 2016-09-09 | |||
| 2016-03-31 | $5.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | $4.11M derived: sum of 2 quarters · filed 2017-05-10 | $467.00K 10-Q · filed 2017-05-10 | $467.60K 10-Q · filed 2016-05-10 | $4.62M derived: sum of 4 quarters · filed 2017-09-28 | |||
| 2015-12-31 | -$909.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$4.55M 10-Q · filed 2017-02-09 | -$4.55M 10-Q · filed 2016-02-09 | -$398.45K derived: sum of 3 quarters · filed 2017-09-28 | -$657.78K derived: sum of 4 quarters · filed 2017-09-28 | |||
| 2015-09-30 | -$3.64M 10-Q · filed 2016-11-09 | -$3.64M 10-Q · filed 2015-11-09 | $510.55K derived: sum of 2 quarters · filed 2017-09-28 | $251.22K derived: sum of 3 quarters · filed 2017-09-28 | -$487.24K derived: sum of 4 quarters · filed 2017-09-28 | |||
| 2015-06-30 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $3.89M derived: sum of 2 quarters · filed 2017-09-28 | $3.15M derived: sum of 3 quarters · filed 2017-09-28 | -$2.45M 10-K · filed 2017-09-28 | -$2.45M 10-K · filed 2015-09-14 | |||
| 2015-03-31 | -$259.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | -$997.79K derived: sum of 2 quarters · filed 2016-05-10 | -$6.60M 10-Q · filed 2016-05-10 | -$22.63M derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-12-31 | -$738.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | -$6.34M 10-Q · filed 2016-02-09 | -$22.37M derived: sum of 3 quarters · filed 2016-09-09 | -$3.08M derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-09-30 | -$5.60M 10-Q · filed 2015-11-09 | -$21.63M derived: sum of 2 quarters · filed 2016-09-09 | -$2.34M derived: sum of 3 quarters · filed 2016-09-09 | -$3.21M derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-06-30 | -$16.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09 | $3.27M derived: sum of 2 quarters · filed 2016-09-09 | $2.40M derived: sum of 3 quarters · filed 2016-09-09 | $4.78M 10-K · filed 2016-09-09 | ||||
| 2014-03-31 | $19.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $18.42M derived: sum of 2 quarters · filed 2015-05-15 | $20.80M 10-Q · filed 2015-05-15 | $20.02M derived: sum of 4 quarters · filed 2015-09-14 | ||||
| 2013-12-31 | -$869.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | $1.51M 10-Q · filed 2015-02-17 | $730.36K derived: sum of 3 quarters · filed 2015-09-14 | -$26.13K derived: sum of 4 quarters · filed 2015-09-14 | ||||
| 2013-09-30 | $2.38M 10-Q · filed 2014-11-14 | $1.60M derived: sum of 2 quarters · filed 2015-09-14 | $843.46K derived: sum of 3 quarters · filed 2015-09-14 | $255.44K derived: sum of 4 quarters · filed 2015-09-14 | ||||
| 2013-06-30 | -$784.29K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | -$1.54M derived: sum of 2 quarters · filed 2015-09-14 | -$2.13M derived: sum of 3 quarters · filed 2015-09-14 | $227.22K 10-K · filed 2015-09-14 | ||||
| 2013-03-31 | -$756.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | -$1.34M derived: sum of 2 quarters · filed 2014-05-15 | $1.01M 10-Q · filed 2014-05-15 | $1.16M derived: sum of 4 quarters · filed 2014-05-15 | ||||
| 2012-12-31 | -$588.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | $1.77M 10-Q · filed 2014-02-14 | $1.92M derived: sum of 3 quarters · filed 2014-02-14 | $1.06M derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2012-09-30 | $2.36M 10-Q · filed 2013-11-14 | $2.50M derived: sum of 2 quarters · filed 2013-11-14 | $1.65M derived: sum of 3 quarters · filed 2013-11-14 | $3.43M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $148.31K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30 | -$708.41K derived: sum of 2 quarters · filed 2013-09-30 | $1.08M derived: sum of 3 quarters · filed 2013-09-30 | $560.46K 10-K · filed 2013-09-30 | ||||
| 2012-03-31 | -$856.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | $929.85K derived: sum of 2 quarters · filed 2013-05-15 | $412.14K 10-Q · filed 2013-05-15 | $360.34K derived: sum of 4 quarters · filed 2013-05-15 | ||||
| 2011-12-31 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | $1.27M 10-Q · filed 2013-02-14 | $1.22M derived: sum of 3 quarters · filed 2013-02-14 | $610.76K derived: sum of 4 quarters · filed 2013-02-14 | ||||
| 2011-09-30 | -$517.71K 10-Q · filed 2012-11-14 | -$569.51K derived: sum of 2 quarters · filed 2012-11-14 | -$1.18M derived: sum of 3 quarters · filed 2012-11-14 | $569.98K derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | -$51.80K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | -$658.11K derived: sum of 2 quarters · filed 2012-10-26 | $1.09M derived: sum of 3 quarters · filed 2012-10-26 | $433.38K 10-K/A · filed 2012-10-26 | ||||
| 2011-03-31 | -$606.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | $1.14M derived: sum of 2 quarters · filed 2012-05-15 | $485.18K 10-Q · filed 2012-05-15 | |||||
| 2010-12-31 | $1.75M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-14 | $1.09M 10-Q · filed 2012-02-14 | ||||||
| 2010-09-30 | -$654.30K 10-Q/A · filed 2011-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |